Outcome or Subgroup	Studies	Participants	Statistical Method	Effect Estimate
1.1 Long-term visual acuity between 20/20 and 20/40	2	108	Odds Ratio(M-H, Fixed, 95% CI)	1.11[0.47, 2.61]
1.2 Short-term visual acuity from 20/20 to 20/40	1		Odds Ratio(M-H, Fixed, 95% CI)	No totals
1.3 Final visual acuity between 20/20 and 20/40	2	143	Odds Ratio(M-H, Fixed, 95% CI)	1.56[0.53, 4.56]
1.4 Time to resolution of primary hemorrhage (days)	6		Other data	No numeric data
1.5 Risk of secondary hemorrhage	6	330	Odds Ratio(M-H, Fixed, 95% CI)	0.25[0.11, 0.57]
1.6 Time to rebleed (days)	6		Other data	No numeric data
1.7 Risk of corneal bloodstain	1		Odds Ratio(M-H, Fixed, 95% CI)	No totals
1.8 Risk of glaucoma or elevated IOP	2	83	Odds Ratio(M-H, Fixed, 95% CI)	0.35[0.06, 1.98]
1.9 Risk of glaucoma or increases in IOP	3		Other data	No numeric data
1.9.1 Transient increase in IOP	1		Other data	No numeric data
1.9.2 Persistant increase in IOP	2		Other data	No numeric data
1.10 Risk of optic atrophy	1		Odds Ratio(M-H, Fixed, 95% CI)	No totals
1.11 Adverse effects: Nausea or vomiting	3	131	Odds Ratio(M-H, Fixed, 95% CI)	11.76[2.59, 53.46]
1.12 Duration of hospitalization (days)	2		Other data	No numeric data